Product Program year 2024 Source: CMS Open Payments

Arthrex

Device Arthroplasty - Implants - Revers Total Shoulder - Modular Glenoid System

PDI 00888867296411

Open in the dashboard

General payments

$2,433,378

44 payments

Research payments

$296,240

6 payments

Through program year 2024, $2,433,378 in general payments and $296,240 in research payments were reported against Arthrex (Revers Total Shoulder - Modular Glenoid System).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

5 rows
Year Kind Amount Payments
2024 General $1,992 32
2024 Research $37,096 3
2023 Research $259,144 3
2022 General $969,435 4
2021 General $1,461,950 8

Breakdown

Who paid General payments · program years 2021–2024
  1. Arthrex, Inc. $2,433,378 44 payments
Top recipients General payments · program year 2024
  1. Daniel Brereton Orthopaedic Surgery · San Diego, CA $177 9% · 1 payment
  2. Cay Mierisch Orthopaedic Surgery · Corvallis, OR $150 8% · 1 payment
  3. Mark Ayzenberg Sports Medicine · Huntingdon Valley, PA $149 8% · 1 payment
  4. Thomas Evely Sports Medicine · Birmingham, AL $125 6% · 1 payment
  5. Theresa Pak Orthopaedic Surgery · Sun City, AZ $118 6% · 1 payment

The top 5 of 27 recipients; each share is of general payments naming this product in 2024.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2024
  1. Orthopaedic Surgery $1,287 65% · 16 practitioners
  2. Sports Medicine Orthopaedic Surgery $429 22% · 6 practitioners
  3. Foot and Ankle Surgery Orthopaedic Surgery $105 5% · 1 practitioner
  4. Nurse Practitioner, Family Nurse Practitioner $55 3% · 1 practitioner
  5. Physician Assistant $46 2% · 1 practitioner

The top 5 of 7 specialties; each share is of general payments naming this product to practitioners with a specialty in 2024. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2024
  1. California $282 14% · 2 recipients
  2. New Jersey $242 12% · 3 recipients
  3. Oregon $237 12% · 3 recipients
  4. Alabama $214 11% · 2 recipients
  5. Florida $208 10% · 3 recipients

The top 5 of 15 states; each share is of general payments naming this product in 2024 where a state was reported.

The top 25 states, free in the app

44 general · 6 research

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2024

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record